Nonetheless, a stronger treatment effect with borderline significance was observed in patients with lung and/or liver disease for alpelisib [ 97 ].
← all excerpts
Role of PI3K/Akt/mTOR pathway in mediating endocrine resistance: concept to clinic.
1
—
—